Remdesivir has “little or no effect on mortality” for patients hospitalized with coronavirus and it doesn’t seem to help Covid-19 patients recover any faster, either.

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

There are also some drugs that have been approved for one purpose, and they may have some efficacy against COVID-19. So there's actually a heartburn drug that's being tried.

Medicines designed to treat COVID-19 won't be available for months, so doctors are looking to drugs already approved for treating other diseases. Coronavirus drugs: Where we are and what we know ...

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and ... Research highlights media misrepresentation of COVID-19 drug efficacy.

Seven Up-and-Coming COVID-19 Drugs. ... who received a single dose of CERC-002 instead of a placebo were alive and free of respiratory failure over the 28-day study period. Efficacy was highest ...

“Future phase III trials will soon confirm or refute the usefulness of this candidate drug as a backbone treatment for COVID-19.” The study authors also highlight some limitations to their study.

The study looked at a variety of literature for drug therapies for COVID-19 -- including hydroxychloroquine, remedesivier, tocilizumab and steroids -- on PubMed.

The SARS-CoV-2 macro domain protein bound to small molecule fragments that could be the basis of novel antiviral drugs. Editor’s note: A manuscript detailing the findings was posted to the bioRxiv ...

Preliminary results from a late-stage study examining the efficacy of the Oxford-AstraZeneca vaccine indicate it is significantly effective at preventing severe illness from COVID-19. Results of ...

That means the experimental drug ought to work equally well no matter how the coronavirus mutates, and the study suggests it does, Wang said. The virus’ shape-shifting ways have ratcheted up the ...